The QualityStocks Daily Friday, December 6th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (TFECF) +43.62%

StockMarketWatch (GCO) +32.27%

MarketClub Analysis (BIG) +31.58%

The QualityStocks Daily Stock List

Aurania Resources Ltd. (AUIAF)

Triple H Stocks, Metals News, The Gold Telegraph, Market Screener, Northern Miner, Geology for Investors, Wallet Investor, Finance Recorder, Junior Mining Network, Stockhouse, Gold Stock Data, TradingView, Investors Hangout, and Dividend Investor reported previously on Aurania Resources Ltd. (AUIAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Aurania Resources Ltd. engages in the identification, evaluation, acquisition and exploration of mineral property interests. A junior mineral exploration company, its emphasis is on precious metals and copper. The Company’s flagship asset is The Lost Cities – Cutucu Project. This Project is in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador. Aurania Resources is headquartered in Toronto, Ontario. The Company lists on the OTC Markets’ OTCQB.

Aurania also has properties in Canton Valais, Switzerland – Siviez (Uranium, Copper and Gold); Marécottes (Uranium); and Mont Chemin (Gold). All of these properties are 100 percent held through the Company’s wholly owned subsidiary AuroVallis SARL.

The Cordillera del Condor – the eastern foothills to the Andes in southeastern Ecuador – hosts a well-endowed mineral belt. It contains 26 million ounces (Moz) of gold and almost 40 billion pounds (Blbs) of copper in NI-43-101 resources held by different companies. The Lost Cities – Cutucu Project lies along-trend of that mineral belt. Therefore, Aurania’s exploration is centered on finding the same kinds of deposits that occur in the Cordillera del Condor.

In late November, Aurania Resources reported that remnants of an old road have been found in the central part of its Lost Cities - Cutucu Project in southeastern Ecuador. The road was discovered by the Company’s field teams while searching for Sevilla de Oro, which was one of two gold mining centers described in historic manuscripts from Ecuador, Peru, Spain and the Vatican.

The records describe the Colonial Spanish operating the two gold mines between about 1565 and 1606. The road discovered by Aurania Resources’ exploration teams is believed to be the one that linked Sevilla de Oro to the other gold mining center 'Logroño de los Caballeros' as described in the historic manuscripts.

This week, Aurania Resources reported that soil sampling shows strong enrichment of copper directly over the Tsenken N2 geophysical feature, which was identified as a second-tier target in the airborne magnetic survey that Aurania completed over its Lost Cities - Cutucu Project. Soil sampling revealed copper enrichment over an area 2,000 metres (m) long by 300m wide. The copper-enriched area corresponds closely with a magnetic feature that has like dimensions. Geological mapping has confirmed the geophysical feature is altered diorite porphyry.

Aurania Resources Ltd. (AUIAF), closed Friday's trading session at $3.0505, off by 2.2276%, on 9,077 volume with 23 trades. The average volume for the last 3 months is 13,945 and the stock's 52-week low/high is $1.64453995/$3.3993299.

chart

Cordoba Minerals Corp. (CDBMF)

Stock Day Media, Mining Stock Valuator, OTC Markets, Equities, Investing News, Morningstar, Proactive Investors, Wallet Investor, Northern Miner, Macroaxis, GlobeNewswire, Dividend Investor, YCharts, Stockhouse, Dividend.com, Otc.watch, Investors Hangout, Seeking Alpha, Nasdaq, Geology for Investors, Market Screener, MarketWatch and Junior Mining Network reported earlier on Cordoba Minerals Corp. (CDBMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Cordoba Minerals Corp. is a mineral exploration company centered on the exploration, development and acquisition of copper and gold projects. It is exploring the San Matias Copper-Gold-Silver Project. This Project includes the Alacran deposit and satellite deposits at Montiel East, Montiel West and Costa Azul, situated in the Department of Cordoba, Colombia. Incorporated in 2009, Cordoba Minerals is based in Vancouver, British Columbia.

Additionally, the Company holds a 25 percent interest in the Perseverance porphyry copper project in the State of Arizona that it is exploring via a Joint Venture (JV) and Earn-In Agreement. In July of 2017, Cordoba Minerals acquired a 100 percent ownership interest in the San Matias Copper-Gold-Silver Project from High Power Exploration, Inc. (HPX). HPX is a privately owned, metals-focused exploration company led by mining entrepreneur Mr. Robert Friedland. HPX owns an approximately 70 percent interest in Cordoba Minerals.

The San Matias Copper-Gold-Silver Project consists of a 20,000 hectare land-package. It contains a number of known areas of porphyry copper-gold and iron oxide copper gold, and/or carbonate replacement deposit mineralization and gold veins. The Project is located close to sea-level in an established mining district with first-rate access and infrastructure.

The San Matias Project is an early stage exploration project. Cordoba Minerals is exploring a newly identified high grade copper-gold district that is characterized by porphyry type and “carbonate replacement” (CRD) type and/or “iron oxide copper-gold” (IOCG) type deposits formed in an accreted island arc setting. Late Cretaceous ages for the magmatism and mineralization are founded on preliminary radiometric age dates.

This past September, Cordoba Minerals announced that it filed a National Instrument 43-101 (NI 43-101) technical report and Preliminary Economic Assessment (PEA) for the San Matias Copper-Gold-Silver Project in Colombia. The NI 43-101 technical report and PEA was independently prepared for Cordoba Minerals by Nordmin Engineering Ltd. with the assistance of Environmental Applications Group, Inc. and Knight Piésold Consulting Ltd.

Last month, Cordoba Minerals announced that JCHX Mining Management Co., Ltd. (JCHX) agreed to make a strategic investment in Cordoba, acquiring a 19.9 percent stake in the Company to advance the San Matias Copper-Gold-Silver Project. Under the terms of the strategic cooperation and investment agreement signed on November 16, 2019 in Beijing, China, Cordoba Minerals will issue 91,372,536 common shares to JCHX via a private placement at a price of C$0.12 per share, yielding gross proceeds to Cordoba of roughly C$11 million.

Cordoba Minerals’ intention is to use the proceeds for completing the work required to secure mining approvals at San Matias, to further explore in the San Matias district, and for working capital and general corporate purposes.

Cordoba Minerals Corp. (CDBMF), closed Friday's trading session at $0.068, up 10.1393%, on 48,000 volume with 3 trades. The average volume for the last 3 months is 32,661 and the stock's 52-week low/high is $0.02666/$0.108000002.

chart

East Asia Minerals Corporation (EAIAF)

Gold Stock Data, Hotstocked, Smart Stock Trading Strategies, TeleTrader, 321gold.com, Investing.com, OTC Markets, Stockwatch, MarketWatch, Northern Miner, Investors Hangout, Seeking Alpha, Stockhouse, Wallet Investor, Dividend Investor, InvestorsHub, Nasdaq, Morningstar, TMXmoney, and Junior Mining Network reported earlier on East Asia Minerals Corporation (EAIAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

East Asia Minerals Corporation is a mineral resource exploration company focused on developing producing precious metals projects in Indonesia. Its emphasis is on developing precious metals projects with major resource upside potential and near-term production capabilities. At present, East Asia Minerals is working on developing the Miwah Project and the Sangihe Project. East Asia Minerals has its corporate office in Vancouver, British Columbia. The Company lists on the OTC Markets.

East Asia Minerals has more than 3.3 million ounces of NI 43-101 gold resource in its two projects. Miwah has 3,140,000 oz Au, open on along strike, across width and at depth, in Protected Forest Reserve. The Miwah Gold Project is situated at the northern tip of Sumatra Island in Aceh Province within the Sumatran fault system. It consists of three contiguous Exploration Mining Business Permits. Miwah is situated southeast of Banda Aceh and consists of 30,000 hectares.

The Sangihe Gold Project is situated on the Taluad and Sangihe Islands, between the northern tip of Sulawesi Island (Indonesia) and the south tip of Mindanao (Philippines). The mineral tenement comprises two blocks encompassing most of the two islands. Sangihe has 266,000 oz Au including near surface oxides for near-term production cash flow. East Asia Minerals holds a 70 percent interest with three Indonesian companies holding the remaining 30 percent interest combined.

In September 2019, East Asia Minerals announced that further to the news release from September 13, 2019, East Asia Minerals subsidiary, PT. Tambang Mas Sangihe or TMS (holder of the Sangihe CoW license) had its detailed works program & business plan (DWP & BP) approved by the Ministry of Energy and Mineral Resources at an open meeting attended by TMS and representatives of Provincial and Central mines departments.

The Ministry of Energy and Mineral Resources and provincial mines department representatives showed strong support and encouragement for the TMS project. They confirmed their commitment to the development of the project. To complete the license upgrade on East Asia Minerals Sangihe project, to Operation Production status, the Company must receive approval of the DWP & BP and the completion of the Environmental Impact Assessment meeting (AMDAL) that will authorize the issuance of the environmental permit.

East Asia Minerals Corporation (EAIAF), closed Friday's trading session at $0.0331, up 3.4375%, on 500 volume with 1 trade. The average volume for the last 3 months is 6,216 and the stock's 52-week low/high is $0.018999999/$0.09397.

chart

FLYHT Aerospace Solutions Ltd. (FLYLF)

Capital Cube, Market Screener, Stockhouse, TipRanks, Dividend Investor, Stockwatch, Seeking Alpha, GlobeNewswire, Nasdaq, TMX Money, InvestorsHub, Wallet Investor, TradingView, and Dividend.com reported previously on FLYHT Aerospace Solutions Ltd. (FLYLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FLYHT Aerospace Solutions Ltd.’s mission is to improve aviation safety, efficiency and profitability. Airlines, leasing companies, fractional owners and original equipment manufacturers (OEMs) have installed FLYHT’s differentiated aircraft and enterprise-based solutions to deliver real-time, flight-deck, satellite connectivity for tracking, health monitoring, and streaming of operational, maintenance and weather data. FLYHT Aerospace Solutions is based in Calgary, Alberta. The OTCQX-listed Company also has an office in Littleton, Colorado.

FLYHT Aerospace’s product family includes Flight Tracking; FDR Streaming; Fuel Management; Iridium Satcom; and FLYHTweather. The Company offers enhanced global flight tracking capabilities, which meet and surpass ICAO’s Global Aeronautical Distress and Safety System (GADSS) definitions for normal and abnormal tracking. In addition, the Automated Flight Information Reporting System (AFIRS™) automates the collection and dissemination of block and flight times.

Moreover, the FLYHTASD™ is a completely integrated and interactive enhanced global flight tracking solution. It makes tracking the progress and monitoring the status of one’s aircraft seamless. FLYHTASD also comes complete with a totally integrated text messaging interface. This allows operators to send and receive text messages to many aircraft at any one time.

The Automated Flight Information Reporting System (AFIRS™) is an Iridium-based SATCOM device installed on the aircraft. It uses FLYHT’s proprietary software to acquire and transmit aircraft data to the ground in real time. This data is then processed and distributed to the customer using FLYHT’s ground server network called UpTime™.

Recently, FLYHT Aerospace Solutions reported financial results for the quarter ended September 30, 2019. Revenues and Other Income increased by 88 percent to $5,820,990 versus Q3 of 2018. Gross Margin was 49 percent of revenue, versus 57 percent in Q3 of 2018. Net Loss was $777,648, versus a Net Loss in Q3 2018 of $953,034.

Mr. Tom Schmutz, FLYHT Aerospace Solutions Chief Executive Officer, said, “During the quarter, FLYHT generated substantial topline revenue growth, press released the selection of AFIRS for the Airbus A220, and began shipping backlog acquired from Panasonic Weather Solutions last October.”

FLYHT Aerospace Solutions Ltd. (FLYLF), closed Friday's trading session at $1.06, up 4.9505%, on 17,200 volume with 17 trades. The average volume for the last 3 months is 7,625 and the stock's 52-week low/high is $0.670000016/$1.46000003.

chart

Ionix Technology, Inc. (IINX)

OTC Markets, GuruFocus, OilandGas360, Simply Wall St, Stockhouse, Last10k, Market Wire News, MarketWatch, Open Insider, Market Screener, Dividend Investor, Small Cap Exclusive, Stockopedia, Wallmine, Financial Content, Wallet Investor, Market Exclusive, YCharts, Proactive Investors, The Street, Morningstar, and TradingView reported beforehand on Ionix Technology, Inc. (IINX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. The Company is focusing on becoming the business aggregator that mainly promotes photoelectric display, smart energy and lead industrial technology development since restructuring. Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions. The OTCQB-listed Company formerly went by the name Cambridge Projects, Inc. It changed its name to Ionix Technology, Inc. in February of 2016.

Ionix Technology has five operating subsidiaries. One is Changchun Fangguan Electronics Technology Co., Ltd, a company that has been focusing on R&D, manufacturing and marketing LCM and LCD. Another is Changchun Fangguan Photoelectric Display Technology Co., Ltd. This subsidiary specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products. Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd. It specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs.

Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking. Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices.

Ionix Technology has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases, to capture the market share of OLED high technology. This past January, the Company announced that it entered into certain VIE Transaction Documents with certain shareholders of Changchun Fangguan Electronics Technology Co., Ltd.

Changchun Fangguan is a leading manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix Technology acquired control of Changchun Fangguan. As a result, Ionix became an aggregator in the photoelectric display and smart energy fields in China, which has also laid a strong foundation for its prospective future development and technology innovation.

Recently, Ionix Technology its financial results for the three months ended September 30, 2019. Total Revenues increased by 192 percent from the three months ended September 30, 2018 to three months ended September 30, 2019. Gross Profit increased by 394 percent from the three months ended September 30, 2018 to three months ended September 30, 2019.

Net Income increased by 302 percent from the three months ended September 30, 2018 to three months ended September 30, 2019. Gross Profit Margin maintained at 19.0 percent during the three months ended September 30, 2019 versus 11.3 percent for the three months ended September 30, 2018.

Ionix Technology, Inc. (IINX), closed Friday's trading session at $1.87, off by 0.531915%, on 2,200 volume with 5 trades. The average volume for the last 3 months is 1,990 and the stock's 52-week low/high is $1.01999998/$2.75.

chart

Rise Gold Corp. (RYES)

24hgold, Junior Mining Network, The Prospector News, Streetwise Reports, Metals News, Geology for Investors, Market Screener, Stockhouse, Newsfile, Pinnacle Digest, Infront Analytics, Wallet Investor, InvestorsHub, Stockwatch, Simply Wall St, Dividend Investor, MarketBeat, Investor Ideas, and Stockopedia reported earlier on Rise Gold Corp. (RYES), and today we report on the Company, here at the QualityStocks Daily Newsletter.

An exploration-stage mining company, Rise Gold Corp.’s principal asset is the historic past-producing Idaho-Maryland Gold Mine located in Nevada County, California. The gold-quartz mines of the Grass Valley-Nevada City District in Nevada County have been the most productive in California. The Idaho-Maryland Gold Mine was a major past producer, yielding 2,414,000 oz of gold at an average mill head grade of 17 gpt gold from 1866-1955. The OTCQB-listed Company formerly went by the name Rise Resources, Inc. It changed its corporate name to Rise Gold Corp. in April of 2017. Established in 2007, Rise Gold is based in Vancouver, British Columbia.

There exist numerous exploration targets on this property that is fully owned by Rise Gold. This includes surface and mineral rights. The Company has 100 percent ownership on what is private land (2,800 acres of subsurface land; 175 acres of industrial land). The property has all the mineral rights of the historic Idaho-Maryland Mine and there are no royalties on future gold production.

The Idaho-Maryland Gold Mine features advanced targets with known mineralization. The Mine was one of the most prolific past gold producers in the United States. It was forced by the U.S. government to shut down in 1942 at peak production for WWII. It was the second largest lode gold mine in the entire United States before shutdown. A major expansion to double production was completed in 1942 before shutdown.

In November, Rise Gold announced that it submitted an application for a Use Permit to Nevada County to allow the re-opening of the Idaho-Maryland Gold Mine (IM Mine). Rise Gold is fully financed to complete the County permitting process. The Company has recently completed 67,500 feet (20,600 meters) of exploration core drilling at the IM Mine. Many high-grade gold intercepts have been encountered, near the existing mine workings and to depths significantly below historic mining areas.

The Use Permit application proposes underground mining to restart at an average throughput of 1,000 tons per day. The existing Brunswick Shaft that5 extends to approximately 3400 feet depth below surface, would be used as the main rock conveyance from the IM Mine.

Rise Gold Corp. (RYES), closed Friday's trading session at $0.05, up 17.6471%, on 273,300 volume with 13 trades. The average volume for the last 3 months is 129,604 and the stock's 52-week low/high is $0.039999999/$0.100000001.

chart

Blockchain Industries, Inc. (BCII)

BlockchainStocks, Dividend Investor, 4-Traders, Trading View, Last10k, OTC Markets, Stockopedia, Stockhouse, Wallet Investor, Wallmine, Whale Wisdom, Simply Wall St, and MarketWatch reported earlier on Blockchain Industries, Inc. (BCII), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blockchain Industries, Inc. is a merchant bank focused on the global blockchain and cryptocurrency sectors. It consists of a Blockchain Technology Advisory, an Investment Management arm, and a Global Conference Series (Blockchain Unbound) connecting entrepreneurs and investors. The Company previously went by the name Omni Global Technologies, Inc. It changed its name to Blockchain Industries, Inc. in November of 2017. Blockchain Industries is headquartered in Santa Monica, California.

The Company’s corporate mission is to make Blockchain Technology accessible, transparent and compliant. Blockchain Industries concentrates on long-term results - in innovation that can help governments streamline their processes, rebuild struggling economies, transform legislative practices, revolutionize healthcare and education, and ultimately better humanity.

Blockchain Industries offers early access to coveted protocols and token issuances, and considerable technical competence, an extensive industry network, and a recognized global brand. In addition, it offers top-tier experiences in finance and operations with an emphasis on compliance and risk management.

The Company’s intention is to offer investment management for blockchain-related assets; and blockchain advisory services. This includes architecting token structure and issuance, crypto-economic design, technology/engineering, consulting, generating whitepapers, software development, and marketing. Additionally, its intention is to invest in, partner with, or acquire media streams, news outlets, or other content distribution methods centered on the marketing of blockchain technologies and Digital Asset economies; partner with educational institutions to train blockchain developers; and set up cryptocurrency mining facilities.

Recently, GoChain announced it has partnered with IriSafe, Inc. and Blockchain Industries to develop blockchain-based identity management solutions. IriSafe is a Singapore-based joint venture (JV) between IriTech and Blockchain Industries. With guidance from Blockchain Industries, GoChain and IriSafe entered a binding joint development agreement.

GoChain will take advantage of IriTech's biometrics hardware and software development kits in collaboration with IriSafe to provide the world's first blockchain identity management solutions using ultra-secure, government-tested and certified iris-scanning technology. These solutions will be constructed on GoChain's best-performing public web3-based network, giving users quicker transaction speeds and enterprise-level support that are not available with traditional identity management solutions.

Blockchain Industries, Inc. (BCII), closed Friday's trading session at $1.47, up 63.3333%, on 117 volume with 2 trades. The average volume for the last 3 months is 333 and the stock's 52-week low/high is $0.700100004/$5.0999999.

chart

Gratitude Health, Inc. (GRTD)

Penny Stock Hub, Dividend Investor, Morningstar, Stockhouse, GuruFocus, Cannabis Daily, Zacks, Wallet Investor, Simply Wall St, MarketWatch, Investors Hangout, InvestorsHub, Trading View, The Street, Barchart, and 4-Traders reported previously on Gratitude Health, Inc. (GRTD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Gratitude Health, Inc. manufactures, sells, and markets functional ready-to-drink (RTD) beverages under the Gratitude brand. The Company’s Founders, Mr. Roy Warren and Mr. Andy Schamisso, are beverage veterans with more than three decades of experience in the industry. Gratitude Health was formed to manufacture healthy, unique, and certified-organic beverages for a consumer market interested in healthy aging. Established in 2017, Gratitude Health is based in North Palm Beach, Florida and lists on the OTCQB.

Gratitude Health announced last year that it entered into a definitive exchange and spinoff agreement with Vapir Enterprises, Inc., previously traded under the symbol VAPI. The combination facilitated Gratitude Health, Inc. to become a publicly traded company. With the agreement, Vapir Management retains its operations, intellectual property (IP), assets, and liabilities. It will continue as a separate operating entity and will not be involved in the beverage business. Vapir is a developer and manufacturer of vaporization devices.

Gratitude Health offers flavored and unsweetened RTD teas. The Company’s alternative food and beverage options are nutrient rich. They feature reduced or eliminated carbohydrate and sugar levels. Moreover, they are full of anti-oxidants and organic ingredients. Each bottle contains no more than 45 calories. Gratitude Health’s 16 oz proprietary bottles feature collectible debossed designs intended to be reused and repurposed.

The Company pan-roasts its tea by hand. Its tea flavors include Dragon Well Green Tea Peach; Dragon Well Green Tea Mint; Dragon Well Green Tea Wildberry; Dragon Well Green Tea Blood Orange; and Dragon Well Green Tea Original. Dragon Well tea (culturally known as "Longjing") comes from the pristine, certified-organic fields of Hangzhou China. Dragon Well tea has the distinction of being named "The Tea of Emperors". It is the most popular in The People’s Republic of China (PRC).

Gratitude Health’s next proprietary product line will further advance the Company mantra of providing healthy, functional drink offerings by specifically targeting what Gratitude call’s “nutrition for aging.” The forthcoming line of innovative, nutrition-rich and balanced meal-replacement drinks will provide a scientifically proven weapon to battle this disease. Therefore, Gratitude Health has contracted with a world-class scientific advisory body to develop ketogenically balanced macro-nutrient delivery. The Company is nearing the end of this formulation and development process.

Recently, Gratitude Health announced its plans to launch KetoRefuel™. This is the world’s first Ready-to-Drink (RTD) line of ketogenic meal-replacement shakes. This product is targeted for launch in Q2 2019. The first drinks to launch in the KetoRefuel lineup will be Chocolate, Vanilla and Caffeinated Mocha Ketogenic Meal-Replacement Shakes in 16.9 oz, shelf-stable Tetra Pak® containers that are re-sealable and have been consumer-tested for user-friendliness.

Gratitude Health, Inc. (GRTD), closed Friday's trading session at $0.0151, even for the day, on 67,980 volume with 7 trades. The average volume for the last 3 months is 7,154 and the stock's 52-week low/high is $0.0114/$0.109899997.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, Research Pool, TradingView, Marketwired, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, 4-Traders, Midas Letter, Daily Marijuana Observer, Weed Newswire, Wallet Investor, The Street, InvestorsHub, Business Insider, Investing News, Cannabis Newswire, Investors Hangout, Stockhouse, Barchart, and Primed Equities reported previously on Beleave, Inc. (BLEVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. Additionally, the OTCQX-listed Company has patient services clinics operating throughout Ontario under the Medi-Green brand. Its wholly-owned subsidiary is Beleave Kannabis Corp. Beleave earlier closed on the acquisition of the Medi-Green Cannabis Clinic Network. London, Ontario is Beleave’s fourth clinic joining three Ontario locations already open in Hamilton, Kingston, and Perth. Beleave is headquartered in Oakville, Ontario.

Beleave has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market in 2019. Its Hamilton, Ontario laboratory is undergoing expansion to make room for methods to formulate cannabis extracts into soluble, flavorless powders, sugar crystals, and syrups for use in beverages and food products using stability-enhancing techniques for prolonged shelf-life.

The Company’s aim is to provide a consistent, reliable and standardized product to suit the needs of every person. Beleave concentrates on green initiatives. It grows its plants using no pesticides. Furthermore, its facilities host a large-scale, commercial, solar installation that substantially offsets its carbon footprint. Beleave’s water supply is on a closed loop system to recycle every drop.

Beleave’s products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain named Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

In July of 2018, Beleave announced the acquisition of 100 percent of the outstanding shares of Seven Oaks, Inc. This acquisition follows important news of Seven Oaks branded cannabis products being chosen by Manitoba Liquor and Lotteries Corporation and the BC Liquor Distribution Branch for sale to consumers in deals expected to produce initial revenues of more than $2,900,000. Beleave will offer Seven Oaks-branded cannabis flower, pre-rolls, and oils.

Beleave announced this past November that it secured genetics acquisition agreements for a broad assortment of cannabis seed varieties from different lineages. There will be 90 new varieties introduced in 2019. These have been selected to cover the entire spectrum of low, intermediate, and high THC and CBD profiles.

Recently, Beleave announced that its wholly-owned subsidiary Beleave Kannabis was authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended license with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.

Beleave, Inc. (BLEVF), closed Friday's trading session at $0.019, up 35.7143%, on 74,405 volume with 7 trades. The average volume for the last 3 months is 103,874 and the stock's 52-week low/high is $0.0131/$0.117150001.

chart

Thin Film Electronics ASA (TFECF)

Speculating Stocks, Dividend Investor, Wallet Investor, Penny Stock Millionaire, Penny Stock Tweets, Stockhouse, TradingView, OTC Markets, InvestorsHub, The Street and 4-Traders reported earlier on Thin Film Electronics ASA (TFECF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Thin Film Electronics ASA provides near field communication (NFC) mobile marketing and smart-packaging solutions by printed electronics technology. It provides end-to-end mobile marketing solutions that feature hardware, label/packaging integration services, and a robust cloud-based software platform.

OTCQX-listed, Thin Film Electronics is based in Oslo, Norway. Additionally, the Company has offices in Silicon Valley, Sweden, San Francisco, London, and Shanghai.

Thin Film’s vision is to make everyday items ‘just smart enough’, thus, effectively extending the traditional boundaries of the IoT to create the Internet of Everything. The Company has 270 patents and patents-pending.

Thin Film’s products include NFC Solutions. NFC involves hardware and software designed with volume production in mind. NFC Solutions isbuilt on highly scalable printed electronics technology. NFC features OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. In addition, it features SpeedTap™ Technology - Single-ID tag.

Moreover, Thin Film’s products include EAS Tags. These are for retailers to strengthen their retail loss-prevention programs with next-generation anti-theft tags. The Company’s 8.2MHz tags are compatible with globally installed infrastructure. Integrated EAS maximizes product availability and minimizes loss. EAS Tags also reduce overhead associated with hard tag application and removal.

This past November, Thin Film announced it received the IDTechEx Technical Development in Manfacturing award in recognition of its pioneering roll-to-roll printed electronics fab in San Jose, California. The IDTechEx Awards were presented as part of the Printed Electronics USA 2018 conference. They recognize company development and success in the field of printed electronics.

The Technical Development in Manufacturing award recognizes the most significant development of a manufacturing device, process, or production plant in the industry over the last 24 months. Award recipients must demonstrate the optimization of a lab-scale or mass-scale production process through improving productivity, quality, reliability, uniformity, or scale.

Thin Film’s San Jose facility features a 22,000 sq-ft printed electronics factory, which is the world’s first production roll-to-roll (R2R) printed electronics line using stainless steel substrates. The design of the fab is for an annual production capacity of up to seven billion units. It is optimized to enable production of low-cost, mechanically strong devices enabling high-volume applications. This includes NFC (near field communication) for mobile marketing, authentication, as well as supply chain services.

Thin Film Electronics ASA (TFECF), closed Friday's trading session at $0.2542, up 43.6158%, on 5,425 volume with 2 trades. The average volume for the last 3 months is 6,201 and the stock's 52-week low/high is $0.119999997/$2.00.

chart

Anfield Energy, Inc. (ANLDF)

Streetwise Reports, InvestorsHub, MarketWatch, OTC Markets, Stockhouse, and Investing News reported on Anfield Energy, Inc. (ANLDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Anfield Energy, Inc. engages in the acquisition, exploration, development, and production of mineral properties in the United States. The Company is a uranium development and near-term production enterprise. Anfield is concentrating on two production centers - the Irigary ISR (in-situ recovery) processing plant in Wyoming and the Shootaring Canyon Mill in Arizona/Utah. Anfield Energy is based in Vancouver, British Columbia.

The Company’s commitment is to becoming a top-tier energy-related fuels supplier through creating value via sustainable, efficient growth in its energy metals assets. Its uranium assets comprise conventional mining claims and State leases in southeastern Utah, Colorado, and Arizona. Anfield’s conventional uranium assets include the Velvet-Wood Project, the Frank M Uranium Project, and the Findlay Tank breccia pipe.

The Company’s key asset is the Shootaring Canyon Mill in Garfield County, Utah. The Shootaring Canyon Mill is strategically located within one of the historically most prolific uranium production areas in the United States. Furthermore, it is one of only three licensed uranium mills in the United States. In 2017, Anfield Energy continued advancing the Shootaring Canyon Uranium Mill license towards operational status with the Utah Division of Waste Management and Radiation Control.

Concerning the Irigaray ISR Processing Plant (Resin Processing Agreement), the Company’s ISR mining projects are in the Black Hills, Powder River Basin, Great Divide Basin, and Laramie Basin, Shirley Basin, and Wind River Basin regions in Wyoming. These consist of 2,667 federal mining claims, 56 Wyoming State leases, and 15 private leases acquired from Uranium One in September 2016.

Anfield Energy’s Clarkson Hill project consists of roughly 500 acres of the mineral holdings of the Company. The Clarkson Hill project includes 25 unpatented mining lode claims situated about 20 air miles southwest of Casper, Wyoming.

Anfield will evaluate the feasibility of adding a vanadium processing facility to its Shootaring Canyon uranium mill. This reflects its intention to capitalize on potential opportunities as vanadium continues to become an even-more relevant commodity in the energy sector.

Anfield Energy announced in December of 2017 a conceptual vanadium exploration target at its Velvet-Wood Mine in Utah. BRS Engineering completed an Exploration Target report, entitled "Velvet-Wood Vanadium Exploration Target, National Instrument 43-101, Utah, U.S.A.", with effective date of December 11, 2017 that provides a vanadium exploration target of between 6.3Mlbs and 9.7Mlbs at a grade of between 0.4 percent V2O5 and 0.61 percent V2O5.

Anfield engaged BRS Engineering to update the Company’s NI 43-101 Preliminary Economic Assessment (PEA) related to the Velvet-Wood Mine to include a vanadium milling circuit as part of a production scenario.

Recently, Anfield Energy announced the acquisition of an extensive exploration database of mining projects centered chiefly on uranium and vanadium properties in the Western U.S. The new database, together with the Company’s already considerable uranium database, constitutes one of the largest depositories of uranium exploration data in the Western U.S.

Anfield Energy also recently announced that it identified vanadium exploration targets in its recently-acquired exploration database of mining projects in the Western U.S. The targets are in Colorado and Utah. They are considered complementary to the Company’s Utah-based Shootaring Canyon mill as Anfield Energy could include a vanadium processing circuit on this asset. Additionally, these vanadium projects could serve as a potential extended vanadium project pipeline beyond the Velvet-Wood uranium/vanadium project.

Anfield Energy, Inc. (ANLDF), closed Friday's trading session at $0.0804, up 29.4686%, on 15,000 volume with 10 trades. The average volume for the last 3 months is 19,330 and the stock's 52-week low/high is $0.0621/$0.200000002.

chart

Omnitek Engineering Corp. (OMTK)

OTCPicks, Marketbeat.com, FeedBlitz, and Penny Stock Rumble reported earlier on Omnitek Engineering Corp. (OMTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines that utilize the Company’s technology. These provide its international customers with unique alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering has its head office in Vista, California.

The Company’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. The strategic alliance provides an assembly-line remanufacturing process providing the benefits of capacity, consistency, as well as quality. Omnitek Engineering’s commitment is to be at the frontier of technology. In addition, its commitment is to develop pioneering solutions that redefine the future of low emissions, energy independence, and transportation.

Omnitek’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established Omnitek Engineering as a leader in the industry.

The Company has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, first for the extensively-used Mercedes OM904 and OM906 engines. LKQ is a top provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Omnitek Engineering announced in July of 2016 that it received global certification for its patented fuel rail technology. This is founded on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.

Omnitek Engineering will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories (Fullerton, California). The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.

Omnitek will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through using its patented diesel-to-natural gas engine conversion technology. Olson-Ecologic Engine Testing Laboratories will serve as project manager. Olson-Ecologic will be responsible for rigorous testing at its facility before demonstrations under real-life conditions.

Omnitek Engineering Corp. (OMTK), closed Friday's trading session at $0.088, up 35.3846%, on 3,212 volume with 2 trades. The average volume for the last 3 months is 20,739 and the stock's 52-week low/high is $0.039999999/$0.200000002.

chart

Calmare Therapeutics, Inc. (CTTC)

OTCBB Journal, TaglichBrothers, and SmallCapVoice reported earlier on Calmare Therapeutics, Inc. (CTTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Calmare Therapeutics, Inc. (the Calmare Pain Mitigation Therapy™ company) researches, develops, and commercializes chronic, neuropathic pain, and wound affliction devices. Calmare devices sell commercially to medical practices internationally. In addition, they are found in U.S. military hospitals, clinics, and on installations through the Company’s General Services Administration (GSA) military contract (V797P-4300B). Calmare Therapeutics is headquartered in Fairfield, Connecticut.

Calmare’s medical devices provide a non-pharmacological (no drugs), non-addictive (no narcotics), and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. The Company supplements its medical devices with a catalogue of private label neurostimulation and sensory electrodes.

The Company’s flagship medical device is the Calmare® Pain Therapy Device. This is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. Calmare Therapeutics holds a U.S. Food & Drug Administration (FDA) 510k clearance designation (K081255) on its flagship device. This grants it the exclusive right to sell, market, research, and develop the medical device in the United States.

Concerning CALMARE® Pain Therapy Treatment, the device is FDA-cleared for U.S. sales, U.S. patented, and patent pending in other countries, and medically certified in Europe. The Calmare® Pain Therapy Device treats oncologic and neuropathic pain through a biophysical rather than biochemical approach.

In January 2017, Calmare Therapeutics announced it was approved to list and supply four sensory and stimulation electrodes and the Calmare® Pain Therapy Device on the GSA Advantage!® web portal. GSA Advantage! is the online shopping and ordering system, which provides access to thousands of contractors and millions of supplies (products) and services.

Calmare Therapeutics has been a preferred vendor of the U.S. federal government (GSA#V797P-4300b) since 2010. Devices, consumables, as well as related hardware sell to U.S. military hospitals and clinics across the U.S. The Company sells its devices in Europe under CE-mark designation.

Calmare creates partnerships with its clients and customers to maximize their Intellectual Property (IP) assets, reduce time-to-market, and add to their profitability. The Company’s Technology Sourcing Service seeks technologies that fit with customer business goals and presents them as potential licensing or IP acquisition candidates.

Greater than 6,000 chronic pain patients have been successfully treated with Calmare Pain Mitigation Therapy™ since the initial Calmare chronic pain treatment was administered in 2007. Calmare Therapeutics has licensed more than 500 technologies to more than 400 individual organizations.

Calmare Therapeutics, Inc. (CTTC), closed Friday's trading session at $0.11, up 10.00%, on 51,269 volume with 6 trades. The average volume for the last 3 months is 7,855 and the stock's 52-week low/high is $0.011099999/$0.237399995.

chart

Liquefied Natural Gas Limited (LNGLF)

Speculating Stocks, Stock Gumshoe, TipRanks, OilandGas360, Macroaxis, Predict Wall Street, Dividend Investor, Proactive Investors, The Stock Market Watch, Energy and Capital, InvestorsHub, Morningstar, MarketBeat, Stockhouse, MarketWatch, Nasdaq, Emerging Growth, Wallet Investor, GuruFocus, Simply Wall St, Dividend.com, and Seeking Alpha reported earlier on Liquefied Natural Gas Limited (LNGLF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Liquefied Natural Gas Limited’s vision is to be the world's premier provider of mid-scale LNG liquefaction solutions. At present, the Company is developing LNG export terminal projects in the U.S. and Canada having combined aggregate design production capacity of 20 mtpa, with expansion options, using its patented OSMR® liquefaction technology. Liquefied Natural Gas’ corporate offices are based in Houston, Texas. The Company also has offices in Perth, Australia; Lake Charles, Louisiana; and Halifax, Nova Scotia.

Liquefied Natural Gas’ business model applies its wholly owned and developed OSMR® liquefaction technology that focuses on delivering four key principles. These include the industry’s lowest full cycle cost; optimized plant energy efficiency; shortened development and construction schedules; and an overall smaller environmental impact footprint, including decreased carbon emissions relative to other LNG technologies.

The Company has a three-path execution strategy to attain its vision. Path 1 is to develop projects utilizing its OSMR® Technology Solutions. Path 2 is to use the OSMR® Technology Solutions to gain entry into new and existing third-party projects. Path 3 is to license the OSMR® liquefaction technology to third-parties.

LNG Technology Pty Ltd, a wholly owned subsidiary of Liquefied Natural Gas Limited, designed and patented the optimized single mixed refrigerant (OSMR® liquefaction technology) process. OSMR® liquefaction technology is a low cost, highly efficient, environmentally friendly, strong and low risk technology. It has the potential to benefit manifold future LNG projects.

The OSMR® liquefaction technology process combines a number of well-proven, existing technologies into one integrated system. Integration of these main components comprise the core liquefaction process. This results in a plant with the industry's lowest full cycle cost, and a substantially more efficient design arrangement that generates lower emissions and improved project economics.

Liquefied Natural Gas’ portfolio includes Magnolia LNG, a proposed 8 million tonne per annum (mtpa) or greater LNG export terminal in Lake Charles, Louisiana; Bear Head LNG, a proposed 8 - 12 mtpa LNG export terminal in Richmond County, Nova Scotia; and the Optimised Single Mixed Refrigerant (OSMR®) liquefaction technology and process. The Company’s portfolio also includes Bear Paw Pipeline, a proposed 62.5 km gas pipeline lateral to connect gas supply to Bear Head LNG.

Liquefied Natural Gas Limited (LNGLF), closed Friday's trading session at $0.133, up 2.3077%, on 23,700 volume with 9 trades. The average volume for the last 3 months is 142,831 and the stock's 52-week low/high is $0.100000001/$0.433999985.

chart

The QualityStocks Company Corner

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Integrated pharma-supply-chain and care platform Trxade Group’s (OTCQB: TRXD)wholly owned subsidiary, Bonum Health, recently partnered with Benzer Pharmacy to launch the Bonum Health Hubs (http://nnw.fm/5O5eC). To view the full article, visit http://nnw.fm/0Nzt8.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Friday's trading session at $1.30, up 4.00%, on 1,250 volume with 1 trade. The average volume for the last 3 months is 3,339 and the stock's 52-week low/high is $0.230000004/$1.60000002.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

HTC Extraction Systems (TSX.V: HTC) was featured today in a publication from HempWireNews, examining how after continued pressure from government officials and industry players to regulate the hemp industry, the United States Department of Agriculture finally released its interim final rule on hemp. On top of the actual rules, States and Tribes were instructed to create their own state plans and submit them to the USDA for approval. Also today, the company was highlighted in a publication from CBDWire, examining how HTC recently completed the construction of two hemp-biomass processing and storage facilities. To view the full article, visit http://cnw.fm/kZu2Z.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Friday's trading session at $0.24, up 11.6279%, on 127,800 volume with 14 trades. The average volume for the last 3 months is 129,366 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is syndicated internationally and covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. To view the full interview, visit http://cnw.fm/1QfAV. To view the full press release, visit http://cnw.fm/8lf4I. Also today, the company was highlighted in a publication from HempWireNews, examining how after continued pressure from government officials and industry players to regulate the hemp industry, the United States Department of Agriculture finally released its interim final rule on hemp. Additionally, SinglePoint (OTCQB: SING) today announced its entry into an agreement with AFG Distribution of North Carolina to sell, market and distribute the company's newest product, "1606 Original Hemp" - a filtered hemp pre roll. To view the full press release, visit http://cnw.fm/5gKs2.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.0105, up 3.2448%, on 3,383,766 volume with 109 trades. The average volume for the last 3 months is 2,705,655 and the stock's 52-week low/high is $0.009999999/$0.028799999.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Fintech holding company Xalles Holdings (OTC: XALL) is a solutions builder in assisting large business and government entities with e-commerce, payments and financial reconciliation issues. To view the full article, visit http://ccw.fm/g1dPv.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Friday's trading session at $0.0024, up 4.3478%, on 548,200 volume with 16 trades. The average volume for the last 3 months is 1,250,932 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading purveyor of financial information and education for Chinese-speaking investors in the United States and China providing real-time market commentary, analysis, and educational-related services in Chinese character language sets. The products and services offered help investors make informed decisions and meet individualized financial goals. After creating inroads into the lucrative cannabis sector in the United States through its subsidiary CBD Biotech Inc., CIIX is leveraging its own financial expertise to establish itself as a leader in China’s emerging CBD industry.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.20, even for the day, on 7,397 volume with 7 trades. The average volume for the last 3 months is 45,442 and the stock's 52-week low/high is $0.165000006/$0.654999971.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Second-generation marijuana products including edibles and beverages launch in Canada's marijuana market this month, but marijuana stocks still face stiff headwinds from supply headaches and mounting quarterly losses. Is it finally safe to step up and buy leading players like Canopy Growth (NYSE: CGC) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)? Continue reading

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $2.59, off by 1.145%, on 1,564,403 volume with 6,259 trades. The average volume for the last 3 months is 2,343,593 and the stock's 52-week low/high is $2.00/$8.43999958.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQB: PLPRF) is dedicated to providing a consistent cannabis experience with its compliant, dosable and flavorful edibles. To view the full article, visit http://cnw.fm/igH4W.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $1.217, off by 2.64%, on 27,895 volume with 48 trades. The average volume for the last 3 months is 47,570 and the stock's 52-week low/high is $1.08749997/$6.00810003.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc.’s (NASDAQ: SRAX) philosophy about the importance of consumers controlling and owning their own personal digital data has been reinforced by a YouTube video from Apple that tells consumers that their own private information on an iPhone – from personal health to text messages – should remain private. SRAX, a technology firm that permits consumers to control their own digital privacy data, is trending ahead of the curve in that respect. The company has been focused on empowering consumers to take control of their data since its inception.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $1.19, off by 3.252%, on 224,769 volume with 577 trades. The average volume for the last 3 months is 104,493 and the stock's 52-week low/high is $1.12999999/$5.8499999.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, recently inked agreements for increased funding totaling up to $103 million. To view the full article, visit http://cnw.fm/Z8vyA.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Friday's trading session at $0.59415, off by 6.873%, on 1,432,125 volume with 542 trades. The average volume for the last 3 months is 1,345,055 and the stock's 52-week low/high is $0.469300001/$4.38000011.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings (OTC: MCTC), a science-forward, intellectual-property-focused company developing unique hemp-infusion technologies, recently filed its fourth cannabinoid-delivery technology patent (http://cnw.fm/B000e). To view the full article, visit http://cnw.fm/e7Eaq.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Friday's trading session at $0.48, off by 8.6062%, on 15,330 volume with 10 trades. The average volume for the last 3 months is 13,601 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced the strengthening of its board of directors with its intention to appoint a new independent director, Jackie Poriadjian-Asch, on and effective December 10, 2019. According to the update, Poriadjian-Asch is a skilled corporate executive with leading consumer-facing brand expertise. To view the full press release, visit http://cnw.fm/yT2Hd. Also today, the company was highlighted in a publication from CBDWire, examining how SPRWF has launched its newest product – Pūr Dew, an exclusive, full-spectrum CBD oil available under the company’s wellness-focused brand, Blissco (http://cnw.fm/G4tkm). Additionally, CBDWire released a report featuring the company which examines how the list of conditions that cannabidiol can cure is apparently endless. For the past few years, people have been turning to the hemp extract to manage everything from anxiety and insomnia to chronic pain and high blood pressure. There’s even a CBD-based drug approved by the U.S. Food and Drug Administration (FDA) to treat rare and hard to manage pediatric epilepsies.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.475, off by 1.0417%, on 145,013 volume with 154 trades. The average volume for the last 3 months is 547,442 and the stock's 52-week low/high is $0.432000011/$1.7888.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, recently appointed Gregg Smith, founder of a New York-based culture-tech, venture investment firm, as senior advisor to help define LXRP’s leadership strategies. To view the full article, visit http://cnw.fm/fQZL3. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. On Monday, the Health Department in Minnesota announced that come 2020, residents of the state suffering from chronic pain and age-related macular degeneration would be qualified to register for the medical marijuana program.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Friday's trading session at $0.40, off by 2.439%, on 110,579 volume with 63 trades. The average volume for the last 3 months is 94,687 and the stock's 52-week low/high is $0.354999989/$1.6875.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global (OTCQB: SHRG) is a diversified holdings company that owns, operates or controls an interest in various companies specializing in the direct-selling industry. To view the full article, visit http://nnw.fm/Gfgd9. Also today, NetworkNewsWire released a report on the company detailing how SHRG operates or controls an interest in a variety of companies specializing in the direct-selling industry, is capitalizing on two trends that have had a tremendous impact in the direct-selling space this year. Direct Selling News, the only publication dedicated to serving direct selling and network marketing executives in North America, just released an insightful article titled ‘5 Events That Impacted Direct Selling in 2019’ (http://nnw.fm/M5Hd1).

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.11, off by 4.3478%, on 10,200 volume with 2 trades. The average volume for the last 3 months is 38,252 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

chart

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

New York City-based intellectual-property, asset-management company Quest Patent Research’s (OTCQB: QPRC)wholly owned subsidiary Semcon IP Inc. recently resolved all claims and disputes by and between Semcon IP Inc. and AsusTek Computer Inc. relating to Semcon’s Power Management Portfolio. To view the full article, visit http://nnw.fm/kQNs0.

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Friday's trading session at $0.0091, off by 23.5294%, on 26,866 volume with 6 trades. The average volume for the last 3 months is 276,904 and the stock's 52-week low/high is $0.004499999/$0.039999999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.